143 related articles for article (PubMed ID: 27109639)
41. Essential role for IkappaB kinase beta in remodeling Carma1-Bcl10-Malt1 complexes upon T cell activation.
Wegener E; Oeckinghaus A; Papadopoulou N; Lavitas L; Schmidt-Supprian M; Ferch U; Mak TW; Ruland J; Heissmeyer V; Krappmann D
Mol Cell; 2006 Jul; 23(1):13-23. PubMed ID: 16818229
[TBL] [Abstract][Full Text] [Related]
42. Unrelated hematopoietic stem cell transplantation for Cernunnos-XLF deficiency.
Faraci M; Lanino E; Micalizzi C; Morreale G; Di Martino D; Banov L; Comoli P; Locatelli F; Soresina A; Plebani A
Pediatr Transplant; 2009 Sep; 13(6):785-9. PubMed ID: 19067926
[TBL] [Abstract][Full Text] [Related]
43. Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO.
Zhou H; Wertz I; O'Rourke K; Ultsch M; Seshagiri S; Eby M; Xiao W; Dixit VM
Nature; 2004 Jan; 427(6970):167-71. PubMed ID: 14695475
[TBL] [Abstract][Full Text] [Related]
44. Constitutive NF-kappaB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity.
Zhou H; Du MQ; Dixit VM
Cancer Cell; 2005 May; 7(5):425-31. PubMed ID: 15894263
[TBL] [Abstract][Full Text] [Related]
45. MALT1 Protease Activity Is Required for Innate and Adaptive Immune Responses.
Yu JW; Hoffman S; Beal AM; Dykon A; Ringenberg MA; Hughes AC; Dare L; Anderson AD; Finger J; Kasparcova V; Rickard D; Berger SB; Ramanjulu J; Emery JG; Gough PJ; Bertin J; Foley KP
PLoS One; 2015; 10(5):e0127083. PubMed ID: 25965667
[TBL] [Abstract][Full Text] [Related]
46. Targeting MALT1 Proteolytic Activity in Immunity, Inflammation and Disease: Good or Bad?
Demeyer A; Staal J; Beyaert R
Trends Mol Med; 2016 Feb; 22(2):135-150. PubMed ID: 26787500
[TBL] [Abstract][Full Text] [Related]
47. Deficiency of MALT1 paracaspase activity results in unbalanced regulatory and effector T and B cell responses leading to multiorgan inflammation.
Bornancin F; Renner F; Touil R; Sic H; Kolb Y; Touil-Allaoui I; Rush JS; Smith PA; Bigaud M; Junker-Walker U; Burkhart C; Dawson J; Niwa S; Katopodis A; Nuesslein-Hildesheim B; Weckbecker G; Zenke G; Kinzel B; Traggiai E; Brenner D; Brüstle A; St Paul M; Zamurovic N; McCoy KD; Rolink A; Régnier CH; Mak TW; Ohashi PS; Patel DD; Calzascia T
J Immunol; 2015 Apr; 194(8):3723-34. PubMed ID: 25762782
[TBL] [Abstract][Full Text] [Related]
48. Multifunctional roles for MALT1 in T-cell activation.
Thome M
Nat Rev Immunol; 2008 Jul; 8(7):495-500. PubMed ID: 18575460
[TBL] [Abstract][Full Text] [Related]
49. The proteolytic activity of the paracaspase MALT1 is key in T cell activation.
Rebeaud F; Hailfinger S; Posevitz-Fejfar A; Tapernoux M; Moser R; Rueda D; Gaide O; Guzzardi M; Iancu EM; Rufer N; Fasel N; Thome M
Nat Immunol; 2008 Mar; 9(3):272-81. PubMed ID: 18264101
[TBL] [Abstract][Full Text] [Related]
50. The Bcl10-Malt1 complex segregates Fc epsilon RI-mediated nuclear factor kappa B activation and cytokine production from mast cell degranulation.
Klemm S; Gutermuth J; Hültner L; Sparwasser T; Behrendt H; Peschel C; Mak TW; Jakob T; Ruland J
J Exp Med; 2006 Feb; 203(2):337-47. PubMed ID: 16432253
[TBL] [Abstract][Full Text] [Related]
51. Challenges in the use of allogeneic hematopoietic SCT for ectodermal dysplasia with immune deficiency.
Fish JD; Duerst RE; Gelfand EW; Orange JS; Bunin N
Bone Marrow Transplant; 2009 Feb; 43(3):217-21. PubMed ID: 18794870
[TBL] [Abstract][Full Text] [Related]
52. The Paracaspase MALT1 in Cancer.
Gomez Solsona B; Schmitt A; Schulze-Osthoff K; Hailfinger S
Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203553
[TBL] [Abstract][Full Text] [Related]
53. Clinical and Immunological Features of Human BCL10 Deficiency.
Garcia-Solis B; Van Den Rym A; Pérez-Caraballo JJ; Al-Ayoubi A; Alazami AM; Lorenzo L; Cubillos-Zapata C; López-Collazo E; Pérez-Martínez A; Allende LM; Markle J; Fernández-Arquero M; Sánchez-Ramón S; Recio MJ; Casanova JL; Mohammed R; Martinez-Barricarte R; Pérez de Diego R
Front Immunol; 2021; 12():786572. PubMed ID: 34868072
[TBL] [Abstract][Full Text] [Related]
54. Outcome of patients with NEMO deficiency following allogeneic hematopoietic cell transplant.
Chandrakasan S; Marsh RA; Uzel G; Holland SM; Shah KN; Bleesing J
J Allergy Clin Immunol; 2017 Mar; 139(3):1040-1043.e2. PubMed ID: 27744027
[No Abstract] [Full Text] [Related]
55. Successful hematopoietic stem cell transplantation for myelofibrosis in an adult with warts-hypogammaglobulinemia-immunodeficiency-myelokathexis syndrome.
Moens L; Frans G; Bosch B; Bossuyt X; Verbinnen B; Poppe W; Boeckx N; Slatter M; Brusselmans C; Diaz G; Tousseyn T; Flipts H; Corveleyn A; Dierickx D; Meyts I
J Allergy Clin Immunol; 2016 Nov; 138(5):1485-1489.e2. PubMed ID: 27484033
[No Abstract] [Full Text] [Related]
56. Hematopoietic stem cell transplantation for primary immunodeficiencies.
Kang E; Gennery A
Hematol Oncol Clin North Am; 2014 Dec; 28(6):1157-70. PubMed ID: 25459185
[TBL] [Abstract][Full Text] [Related]
57. The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency.
Gámez-Díaz L; August D; Stepensky P; Revel-Vilk S; Seidel MG; Noriko M; Morio T; Worth AJJ; Blessing J; Van de Veerdonk F; Feuchtinger T; Kanariou M; Schmitt-Graeff A; Jung S; Seneviratne S; Burns S; Belohradsky BH; Rezaei N; Bakhtiar S; Speckmann C; Jordan M; Grimbacher B
J Allergy Clin Immunol; 2016 Jan; 137(1):223-230. PubMed ID: 26768763
[TBL] [Abstract][Full Text] [Related]
58. Autophagy-associated immune dysregulation and hyperplasia in a patient with compound heterozygous mutations in
Hu G; Hauk PJ; Zhang N; Elsegeiny W; Guardia CM; Kullas A; Crosby K; Deterding RR; Schedel M; Reynolds P; Abbott JK; Knight V; Pittaluga S; Raffeld M; Rosenzweig SD; Bonifacino JS; Uzel G; Williamson PR; Gelfand EW
Autophagy; 2023 Feb; 19(2):678-691. PubMed ID: 35838483
[TBL] [Abstract][Full Text] [Related]
59. Inherited Human BCL10 Deficiencies.
Alsaidalani AA; García-Solís B; Bukhari E; Van Den Rym A; López-Collazo E; Sánchez-Ramón S; Corvillo F; López-Lera A; de Andrés A; Martínez-Barricarte R; Perez de Diego R
J Clin Immunol; 2023 Dec; 44(1):13. PubMed ID: 38129623
[TBL] [Abstract][Full Text] [Related]
60. Expanding the Clinical and Immunological Phenotypes and Natural History of MALT1 Deficiency.
Sefer AP; Abolhassani H; Ober F; Kayaoglu B; Bilgic Eltan S; Kara A; Erman B; Surucu Yilmaz N; Aydogmus C; Aydemir S; Charbonnier LM; Kolukisa B; Azizi G; Delavari S; Momen T; Aliyeva S; Kendir Demirkol Y; Tekin S; Kiykim A; Baser OF; Cokugras H; Gursel M; Karakoc-Aydiner E; Ozen A; Krappmann D; Chatila TA; Rezaei N; Baris S
J Clin Immunol; 2022 Apr; 42(3):634-652. PubMed ID: 35079916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
